Eyeworld Supplements

5 it gives them such a large sweet spot. Dr. Woodard: Discussing patients' goals ahead of time is absolutely the most important aspect in man- aging patient expectations. Many multifocal patients do not want to compromise distance clarity, so we have all realized over time that many of these patients feel that their distance vision is not quite as crisp as they wish. That's where I feel the +2.5 with ACTIVEFOCUS Optical Design has had a significant impact in my practice. In many cases, my +2.5 patients are reporting very sharp distance vision and strong intermediate vision, and they do not feel like they compromised their vision. I think this is due to the increased neg- ative asphericity as well as the larger monofocal zone in the center. Many of Dr. Tipperman: The suc- cessful +3.0 patients are the poster children for cataract surgery. They are terrific at all distances, and they are very happy; however, if you implant enough of these lenses, you will get patients who are good but not great. Their vision is adequate, but they wish it was a lit- tle bit better. Warren Hill, MD, says that everything in optics is a trade-off. I tell my patients that all of their choices are trade-offs. They can have a monofo- cal lens, which will provide great distance vision and no functional vision from arm's length on in. Or they can have the ReSTOR +2.5, which is designed to pro- vide good monofocal-like distance vision and mid- range vision, but they might need glasses for reading oc- casionally. I find that most patients are comfortable with that approach because excellent distance vision and high-contrast sensitivi- ty, but also functional near vision in low light condi- tions. They are looking for a lens like +2.5 that has multifocal functionality with monofocal-like distance performance. And frank- ly, even some of my older patients are looking for— and will pay for—this type of outcome. I think patient education is very import- ant. It is frightful to implant a multifocal lens and then have the patient be under- whelmed and unhappy. Patients' unhappiness is usually due to halos, glare, starbursts, and various oth- er dysphotopsias, as well as decreased contrast sensitiv- ity. With the ReSTOR +2.5, I have had happier patients. In fact, a lot of patients are overwhelmed. My staff is also happier because they see that the ReSTOR +2.5 patients are really appreci- ating their outcomes. ReSTOR +2.5 with ACTIVEFOCUS TM Optical Design Dr. Lane: Multifocal IOLs continue to be a challenge. From a market share stand- point, it stands right about 7–8% of all IOLs implant- ed in the U.S. and hasn't budged for a few years. We have the ReSTOR +2.5 with ACTIVEFOCUS Optical Design joining the ReSTOR +3.0, which is the most re- cent addition to the AcrySof family of IOLs. What have you learned since using the ReSTOR +2.5 compared to your experience implanting the +3.0? Dr. Cibik: Meeting patients' expectations is difficult. Patients are increasingly more demanding and more perfectionistic. Many of my patients—particularly those who are younger and still working in their mid-60s— are on a quest for not only continued on page 6 ReSTOR +2.5 Outer distance zone Center distance zone Center intermediate zone Outer distance zone Apodized diffractive multifocal zone ReSTOR +3.0 Please refer to page 8 for impor tant product information about the Alcon products described in this supplement.

• Cover